Prognostic value of low skeletal muscle mass in hepatocellular carcinoma patients treated with sorafenib or lenvatinib: A meta-analysis

Growing evidence indicates that skeletal muscle depletion has a notable effect on the prognosis of hepatocellular carcinoma (HCC) patients, though study results are still controversial. Our meta-analysis aimed at evaluating the prognostic significance of low skeletal muscle mass (LSMM) in HCC patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Jun, Yang, Qin, Chen, Chao, Wang, Gang, Zhu, Haihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838828/
https://www.ncbi.nlm.nih.gov/pubmed/33510588
http://dx.doi.org/10.17179/excli2020-3111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838828/
https://www.ncbi.nlm.nih.gov/pubmed/33510588
http://dx.doi.org/10.17179/excli2020-3111

Ejemplares similares